Canada markets close in 5 hours 30 minutes

NervGen Pharma Corp. (NGEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
2.0800+0.0100 (+0.48%)
As of 9:43AM EST. Market open.
Full screen
Previous Close2.0700
Open2.1000
Bid2.0800 x 0
Ask2.1200 x 0
Day's Range2.0800 - 2.1000
52 Week Range0.8000 - 3.2500
Volume5,000
Avg. Volume16,475
Market Cap73.043M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.3120
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    NervGen to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event

    Vancouver, British Columbia--(Newsfile Corp. - January 5, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced that Paul Brennan, President & CEO, will conduct a corporate presentation at the LifeSci Partners 10th Annual Healthcare Corporate Access Event on Wednesday, January 6, 2021 at 3:00pm Eastern Time. Investors interested can pre-register for ...

  • Newsfile

    NervGen Pharma Engages CRO for Phase 1 Clinical Trial

    Vancouver, British Columbia--(Newsfile Corp. - December 15, 2020) -  NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced that it has engaged Novotech (Australia) Pty Limited ("Novotech"), a leading full-service contract research organization ("CRO") in Asia-Pacific, for its upcoming Phase 1 clinical trial for NVG-291. NervGen currently plans to initiate its Phase 1 ...

  • Is NervGen Pharma (CVE:NGEN) In A Good Position To Invest In Growth?
    Simply Wall St.

    Is NervGen Pharma (CVE:NGEN) In A Good Position To Invest In Growth?

    We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...